When it comes to Active Surveillance (AS) decisions, there’s good news and bad news. The good news: based on biopsy results, more doctors are recommending AS for prostate cancer (PCa) patients with insignificant disease. The bad news: the biopsy might have missed significant PCa so the patient can’t know for sure if AS is a keep reading
We all know that high cholesterol increases the risk of heart disease, right? But guess what – it’s a risk factor for prostate cancer. And not just prostate cancer; studies have linked high total cholesterol (“good” plus “bad” cholesterol) with cancer of the colon, testicles and rectum. Cholesterol is one of the fatty substances called keep reading
